Literature DB >> 27651343

Differences in Protein Expression between the U251 and U87 Cell Lines.

Hezhen Li1, Bingxi Lei, Wei Xiang, Hai Wang, Wenfeng Feng, Yawei Liu, Songtao Qi.   

Abstract

AIM: The U251 and U87 cell lines are commonly used as experimental models of glioblastoma. However, these cells exhibit significant differences in their proliferation, invasion, and migration. The aim of the present study was to compare the protein expression profiles of the U251 and U87 cell lines in order to provide a molecular basis for the observed phenotypic differences.
MATERIAL AND METHODS: Isobaric tags for relative and absolute quantitation (iTRAQ) and gene ontology (GO) analyses were performed to detect differentially expressed proteins and to predict protein functions, respectively.
RESULTS: Two hundred and forty-four proteins were highly expressed, while 263 proteins exhibited lower levels of expression, in the U251 cells compared to the U87 cells. In particular, higher expression levels of the proteins, C10orf58, FLNC, PDLIM1, TPM4, and lower expression levels of MYH10, PSIP1, SYNM, SLC9A3R2, BCAM, were verified by qPCR in the U251 cell line versus the U87 cell line. When a GO analysis was applied to the iTRAQ results, the proteins that were highly expressed in the U251 cells were found to differ in their molecular functions, biological processes, cellular distribution, and cellular pathways associated with them compared with the highly expressed proteins detected in the U87 cells.
CONCLUSION: Differentially expressed proteins between the U251 and U87 cell lines are associated with regulation of nicotinamide nucleotide metabolism, RNA splicing, glycolysis, and purine metabolism pathways. Further studies on these pathways may identify whether these various pathways account for the observed phenotype differences between the U87 and U251 GBM cell lines.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27651343     DOI: 10.5137/1019-5149.JTN.17746-16.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  21 in total

1.  Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.

Authors:  Xuexia Zhou; Run Wang; Xuebing Li; Lin Yu; Dan Hua; Cuiyun Sun; Cuijuan Shi; Wenjun Luo; Chun Rao; Zhendong Jiang; Ying Feng; Qian Wang; Shizhu Yu
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

2.  Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity.

Authors:  Kang Yang; Minghai Wei; Zhaofei Yang; Zhenfa Fu; Ruixue Xu; Cheng Cheng; Xi Chen; Sheng Chen; Eric Dammer; Weidong Le
Journal:  Cell Oncol (Dordr)       Date:  2020-08-06       Impact factor: 6.730

3.  LncRNA GAS8-AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation.

Authors:  Xiaoming Wu; Tingting Jiang; Rui Huang; Xue Xiao
Journal:  Brain Behav       Date:  2021-05-04       Impact factor: 2.708

4.  Targeted Chemotherapy of Glioblastoma Spheroids with an Iontronic Pump.

Authors:  Linda Waldherr; Maria Seitanidou; Marie Jakešová; Verena Handl; Sophie Honeder; Marta Nowakowska; Tamara Tomin; Meysam Karami Rad; Tony Schmidt; Joachim Distl; Ruth Birner-Gruenberger; Gord von Campe; Ute Schäfer; Magnus Berggren; Beate Rinner; Martin Asslaber; Nassim Ghaffari-Tabrizi-Wizsy; Silke Patz; Daniel T Simon; Rainer Schindl
Journal:  Adv Mater Technol       Date:  2021-04-12

5.  Alternative new mesenchymal stem cell source exerts tumor tropism through ALCAM and N-cadherin via regulation of microRNA-192 and -218.

Authors:  Ran Kim; Sang In Park; Chang Youn Lee; Jihyun Lee; Pilseog Kim; Sekyung Oh; Hojin Lee; Min Young Lee; Jongmin Kim; Yong-An Chung; Ki-Chul Hwang; Lee-So Maeng; Woochul Chang
Journal:  Mol Cell Biochem       Date:  2016-12-30       Impact factor: 3.396

Review 6.  The mechanobiome: a goldmine for cancer therapeutics.

Authors:  Eleana Parajón; Alexandra Surcel; Douglas N Robinson
Journal:  Am J Physiol Cell Physiol       Date:  2020-11-11       Impact factor: 4.249

7.  Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells.

Authors:  Julia Peñas-Martínez; Ginés Luengo-Gil; Salvador Espín; Nataliya Bohdan; Carmen Ortega-Sabater; Maria Carmen Ródenas; David Zaragoza-Huesca; María José López-Andreo; Carme Plasencia; Vicente Vicente; Alberto Carmona-Bayonas; Irene Martínez-Martínez
Journal:  Biomedicines       Date:  2021-05-07

8.  The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7.

Authors:  Dominique Thuringer; Gaetan Chanteloup; Pascale Winckler; Carmen Garrido
Journal:  Oncotarget       Date:  2018-09-07

9.  Reduction of Human Glioblastoma Spheroids Using Cold Atmospheric Plasma: The Combined Effect of Short- and Long-Lived Reactive Species.

Authors:  Angela Privat-Maldonado; Yury Gorbanev; Sylvia Dewilde; Evelien Smits; Annemie Bogaerts
Journal:  Cancers (Basel)       Date:  2018-10-23       Impact factor: 6.639

10.  Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells.

Authors:  Xihong Liu; Peiyuan Zhao; Xiujuan Wang; Lei Wang; Yingjun Zhu; Yadi Song; Wei Gao
Journal:  J Exp Clin Cancer Res       Date:  2019-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.